Oct 2021 – Dec 2024 · 3 yrs 2 mos · Geneva, Switzerland · On-site

• Led integration of Adacap into Novartis, launching breakthrough therapies across over 30 countries, overcoming regulatory and operational challenges to accelerate patient access and drive double-digit growth.
• Redesigned team structures and market strategies, to enhance efficiency and agility in the evolving healthcare landscape, whilst exceeding targets year-on-year.
• Drove cross-functional innovation in drug development, aligning clinical, commercial and regulatory insights to deliver scalable solutions and expand global market presence.

May 2018 – Oct 2021 · 3 yrs 5 mos · Saint Genis Poully and Ivrea · On-site

• Restructured manufacturing, R&D and commercial operations post-merger; ensuring business continuity, launching in France and Italy while driving business growth.
• Organised a 3,000 sqm manufacturing expansion, scaling the team by 162%.
• Navigated post-merger challenges and spearheaded launches, building leadership teams, influencing industry standards, and driving market growth across European regions.

Oct 2014 – Apr 2018 · 3 yrs 6 mos · Origgio · On-site

• Transformed business operations across 14 European countries, driving 45% positive revenue growth through strategic innovation in oncology and rare disease sectors.
• Launched several pharmaceutical brands in key therapeutic areas, with significant market adoption.
• Dedicated over 70% of the time to on-the-ground engagement, collaborating with local teams to enhance brand visibility and driving strategic alignment with key opinion leaders and decision-makers.

Mar 2012 – Oct 2014 · 2 yrs 7 mos · Origgio · On-site

• Redesigned a new market access strategy across 38 European countries, securing reimbursement for over 15 brands across oncology and rare disease portfolios.
• Successfully launched key brands, accelerating reimbursement timelines and leveraging evidence generation from relevant trials and studies.
• Recognised with the Novartis Global President Award for delivering innovative, high-value solutions and contributing to strategic acquisitions, while developing future leadership talent.

Jan 2009 – Sep 2009 · 8 mos · Milan, Lombardy, Italy · On-site

• Built a new market access structure at Schering Plough across all franchises, including primary care, specialty, animal health, generics and OTC.
• Drove effective structure implementation by redeployment of internal resources.

Jan 2007 – Dec 2008 · 1 yr 11 mos · Milan, Lombardy, Italy · On-site

• Transformed IMS Health's offering from sales data analytics to market access consultancy, exceeding sales targets and pioneering new analytics with longitudinal patient data. This innovation enabled real-world evidence generation and introduced a novel service for clients.
• Completed the acquisition and transformation of AboutPharma, doubling the journal's size, increasing advertising and sponsorship revenues, and enhancing the education academy with CME courses for pharmacists and doctors, generating additional revenue streams.

Mar 2002 – Mar 2012 · 10 yrs · London and Milan · On-site

• Established the market access function in Italy, securing significant successes in price and reimbursement negotiations for key products.
• Built the European market access function during a secondment in London.
• Contributed to setting the access strategy as a member of the Global Strategic Market Access Board, the European Governmental Affairs Leadership Team and the European Strategy Steering Committee for innovative channels and mature brand business development.
• Managed key account and regional affairs teams as Vice President of the Italian affiliate, overseeing 45 key account managers and 13 regional affairs managers.
• Successfully mitigated turnover gaps and led a major organisational restructuring in collaboration with unions.

Nov 1997 – Mar 2002 · 4 yrs 4 mos · Firenze · On-site

• Transitioned from clinical practice to the pharmaceutical industry, growing within the organisation and manage critical international functions across international regulatory affairs, pricing, and health economics.
• Contributed to strategic business development and licensing (BD&L), playing a key role in licensing co-marketing assets and facilitating a merger.
• Supported GMP and FDA audits in Pisa and L’Aquila, ensuring compliance and facilitating successful audit outcomes.
• Collaborated on evidence generation plans with R&D, enhancing global drug registration and pricing strategies in Italy and the EU.

Oct 1993 – Oct 1997 · 4 yrs